Encellin Announces Interim Clinical Results Showing First-in-Human Non-Fibrotic Engraftment and Viable Encapsulated Human Islets in Subjects with Type 1 Diabetes

Written By Lara Wilson
Lara Wilson
Previous

Vivere Oncotherapies Announces >$10M Funding to Develop Targeted Therapies for Solid Tumors
Next

SixMap Launches New Product Capabilities to Improve Cyber Defense in the Face of AI-Driven Attacks